Mark Leuchtenberger

Mark Leuchtenberger

Presidente presso NEUROSENSE THERAPEUTICS LTD.

Patrimonio netto: 80 640 $ in data 30/04/2024

67 anni
Health Technology
Consumer Services
Commercial Services

Provenienza dei contatti di primo grado di Mark Leuchtenberger

EntitàTipo di entitàSettore Industriale
Wake Forest University
47
College/University Other Consumer Services 47
18
Extinct Biotechnology 18
Public Company Pharmaceuticals: Major 15
Subsidiary Pharmaceuticals: Major 12
9
Holding Company Biotechnology 9
6
Extinct Pharmaceuticals: Major 6
4
Extinct Pharmaceuticals: Major 4
4
Holding Company Pharmaceuticals: Major 4
Public Company Pharmaceuticals: Major 3
2
Extinct Pharmaceuticals: Major 2
Public Company Pharmaceuticals: Major 2
Public Company Pharmaceuticals: Major 2
1
Subsidiary Pharmaceuticals: Major 1

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Mark Leuchtenberger tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
Biotechnology

Neal M. Farber

Roy R. Lobb

Corporate Officer/Principal

Corporate Officer/Principal

HILLSHIRE BRANDS CO Food: Meat/Fish/Dairy

Daniel M. Delen

Jane Brightwell

Corporate Officer/Principal

Corporate Officer/Principal

MERRILL LYNCH PREFERRED CAPITAL TRUST I Major Banks

Adelaide Sink

Thomas W. Bunn

President

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Pierre E. G. Etienne

Ronald Guido

Chief Operating Officer

Director/Board Member

Tobacco

Andrew J. Schindler

Daniel M. Delen

Chief Executive Officer

Chief Executive Officer

Pharmaceuticals: Major

David I. Gwynne

Elkan R. Gamzu

Corporate Officer/Principal

President

Pharmaceuticals: Major

Vincent J. Miles

Elkan R. Gamzu

Corporate Officer/Principal

Corporate Officer/Principal

BIOGEN INC. Pharmaceuticals: Major

James Tobin

Daniel Char

Roy R. Lobb

Caren Deardorf

Ferenc Tracik

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

CURIS, INC. Biotechnology

James Tobin

George Eldridge

Director/Board Member

Director of Finance/CFO

Wake Forest School of Medicine College/University

Matthew King

Mitesh B. Shah

Michael Batalia

Chairman

Director/Board Member

Director/Board Member

Medical Specialties

Joshua D. Hamermesh

Colleen Wilson

Corporate Officer/Principal

Human Resources Officer

AEGERION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Christine Pellizzari

Mark J. Fitzpatrick

General Counsel

Director of Finance/CFO

Tobacco

Andrew J. Schindler

Daniel M. Delen

Chief Executive Officer

Chief Executive Officer

TETRAPHASE PHARMACEUTICALS, INC. Pharmaceuticals: Major

Garen Bohlin

Eric M. Gordon

Director/Board Member

Director/Board Member

Medical Specialties

Charles Iacovou

Kim Westmoreland

Director/Board Member

Director/Board Member

College/University

William G. Ward

C. Nye

Kim Westmoreland

David N. LaMond

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Graduate Degree

College/University

Neal M. Farber

Thomas Schuetz

Daniel L. Menichella

Corporate Officer/Principal

Doctorate Degree

Undergraduate Degree

University of Pennsylvania College/University

Andrew J. Schindler

Elkan R. Gamzu

Darryl L. Landis

Masters Business Admin

Doctorate Degree

Undergraduate Degree

George Washington University College/University

Jane Brightwell

Anand Varadan

Graduate Degree

Undergraduate Degree

The Hebrew University of Jerusalem College/University

Elkan R. Gamzu

Oron Yacoby-Zeevi

Dror Brandwein

Nedira Salzman-Frenkel.

Undergraduate Degree

Doctorate Degree

Graduate Degree

Graduate Degree

The University of North Carolina at Charlotte College/University

Scott E. Reed

Donald C. Ingram

Daniel L. Menichella

Michael Batalia

Masters Business Admin

Undergraduate Degree

Masters Business Admin

Corporate Officer/Principal

Harvard Business School College/University

H. Culp

James Tobin

Joshua D. Hamermesh

Stéphane Bancel

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Ben-Gurion University of the Negev College/University

Oron Yacoby-Zeevi

Nedira Salzman-Frenkel.

Alon Ben-Noon

Doctorate Degree

Undergraduate Degree

Masters Business Admin

Medical/Nursing Services

Andrew J. Schindler

Matthew King

Boris Pasche

Director/Board Member

Director/Board Member

Director/Board Member

Packaged Software

Christopher Guiffre

William Greene

Director of Finance/CFO

Founder

ALNYLAM PHARMACEUTICALS, INC. Pharmaceuticals: Major

Vincent J. Miles

Roy R. Lobb

Corporate Officer/Principal

Corporate Officer/Principal

Bar-Ilan University College/University

Revital Mandil–Levin

Hagit Binder

Doctorate Degree

Graduate Degree

NEURODERM LTD Biotechnology

Revital Mandil–Levin

Oron Yacoby-Zeevi

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

INFINITY PHARMACEUTICALS, INC. Pharmaceuticals: Major

Joshua D. Hamermesh

Colleen Wilson

Corporate Officer/Principal

Human Resources Officer

KARYOPHARM THERAPEUTICS INC. Pharmaceuticals: Major

Garen Bohlin

Anand Varadan

Director/Board Member

Corporate Officer/Principal

Investment Managers

Eric M. Gordon

Thomas Schuetz

Chairman

Corporate Officer/Principal

The University of Texas at Austin College/University

Brig Sorber

Michael Batalia

Director/Board Member

Doctorate Degree

The University of North Carolina at Chapel Hill College/University

David W. Dupree

Thomas W. Bunn

Undergraduate Degree

Masters Business Admin

Investment Managers

Matthew King

Kim Westmoreland

Private Equity Investor

Consultant / Advisor

The College of Management Academic Studies College/University

Chaime Orlev

Revital Mandil–Levin

Undergraduate Degree

Masters Business Admin

Pharmaceuticals: Major

H. Culp

Eddie J. Gray

Director/Board Member

Sales & Marketing

Indiana University College/University

Elizabeth J. Gatewood

Lynn Sadowski Mason

Corporate Officer/Principal

Undergraduate Degree

University of Wisconsin College/University

Ekaterina Smirnyagina

Eric M. Gordon

Doctorate Degree

Doctorate Degree

Williams College College/University

Walter Ogier

Jay Venkatesan

Undergraduate Degree

Undergraduate Degree

Rutgers State University of New Jersey College/University

Scott E. Reed

Cary Claiborne

Undergraduate Degree

Undergraduate Degree

College/University

Diana Shtossel

Shiran Zimri

Graduate Degree

Doctorate Degree

Tufts University College/University

Daniel Char

Caren Deardorf

Undergraduate Degree

Undergraduate Degree

Investment Managers

Matthew King

Kim Westmoreland

Private Equity Investor

Consultant / Advisor

Investment Managers

Vincent J. Miles

Roy R. Lobb

Private Equity Investor

Corporate Officer/Principal

Medical/Nursing Services

Matthew King

Kim Westmoreland

Director/Board Member

Chairman

Statistiche

Distribuzione geografica

Stati Uniti 43
Israele 7
Norvegia 2

Settori

Consumer Services 20
Health Technology 17
Finance 8
Consumer Non-Durables 4
Health Services 3

Posizioni

Director/Board Member 409
Corporate Officer/Principal 238
Chief Executive Officer 77
Independent Dir/Board Member 76
Undergraduate Degree 62
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA